• Users Online: 9
  • Print this page
  • Email this page
Year : 2018  |  Volume : 11  |  Issue : 2  |  Page : 81-83

Transient neonatal diabetes in extremely low-birth-weight baby treated with long-acting insulin (Glargine)

1 Department of Paediatrics, Neonatal Intensive Care Unit, Dubai Hospital, Dubai, United Arab Emirates
2 Department of Paediatrics, Paediatric Endocrinology Unit, Dubai Hospital, Dubai, United Arab Emirates

Correspondence Address:
Khalid Iqbal
Department of Paediatrics, Neonatal Intensive Care Unit, Dubai Hospital, Dubai
United Arab Emirates
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/HMJ.HMJ_14_18

Rights and Permissions

Neonatal diabetes mellitus (NDM) is not uncommon amongst extreme preterm or extremely low-birth-weight (ELBW) neonates. The treatment for NDM to achieve normoglycemia is not without challenges because of lack of one ideal strategy for appropriate treatment. The management of NDM begins with insulin, but it is very difficult to adjust the doses and route of administration because of the dilemma of frequently developing hypoglycaemia and then hyperglycaemia again after stopping insulin. We report here an ELBW baby initially treated with regular insulin and then glargine, long-acting insulin, was administered subcutaneously as once daily dose with successful control of hyperglycaemia. Previously, two cases have been reported where glargine was used to control NDM. The possibility of recommendation for successful treatment with subcutaneous long-acting insulin to treat NDM amongst ELBW neonates is discussed.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded149    
    Comments [Add]    

Recommend this journal